image
Prelude Therapeutics Incorporated PRLD
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.7987
-1.4 %
$ 45.1 M
Market Cap
-0.48
P/E
Price Target Average
758.54%
Revenue Forecast Estimate
96.08%
EBIT Estimate
25.04%
Net Income Estimate
15.14%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Prelude Therapeutics Incorporated
image
Wall Street analysts predict an average 1-year price target for PRLD of $6.86 , with forecasts ranging from a low of $3 to a high of $15 .
PRLD Lowest Price Target Wall Street Target
3 USD 275.61%
PRLD Average Price Target Wall Street Target
6.86 USD 758.54%
PRLD Highest Price Target Wall Street Target
15 USD 1778.05%
Price
Max Price Target
Min Price Target
Average Price Target
16161414121210108866442200Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart PRLD

image
$120.0m$120.0m$100.0m$100.0m$80.0m$80.0m$60.0m$60.0m$40.0m$40.0m$20.0m$20.0m$0.0$0.020232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart PRLD

image
$100.0m$100.0m$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)20232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart PRLD

image
$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)($60.0m)($60.0m)($80.0m)($80.0m)($100.0m)($100.0m)($120.0m)($120.0m)($140.0m)($140.0m)20232023202420242025202520262026202720272028202820292029